The popularity of Viagra initially fueled a surge for pharma, however recent changes present a complicated picture for those considering a stake. Lower-cost versions are eroding revenue, and persistent legal battles https://berthafveb062355.jiliblog.com/97573617/the-blue-pill-and-pharma-a-volatile-investment